Literature DB >> 11516049

The CGHA asthma management program and its effect upon pediatric asthma admission rates.

E Martin1.   

Abstract

Asthma is the most common reason for admission to the hospital for children nationally. This hospitalization rate is stable despite availability of appropriate outpatient treatments. Our Cincinnati Group Health Associates (CGHA) asthma management program has evolved since 1989. We have measured our pediatric population along with asthma admissions since 1993. Our admission pattern is compared to the community in general and to our managed care population in particular. Our urban center's admission pattern is also studied. Our CGHA pediatric asthma admissions have been declining steadily over the 1993-2000 period by 60%. This decrease is in contrast to national trends in this time period. Comparison to total admissions from 1993 through 2000 still shows a 50% decline whether 0-18 years or 0-5 years is studied. Our urban pediatric center also had a fall in pediatric asthma admission rates of 80% in this time frame; all of these results are statistically significant. Our major managed care network also showed a decline of 55% in pediatric asthma admissions from 1996 to 1999. Our CGHA asthma management program has had a positive influence on our pediatric asthma admission rates. This effect is favorable in comparison to national trends in pediatric asthma admissions. This trend is independent of disease acuity, region of the city where patients live, insurance selection, or age.

Entities:  

Mesh:

Year:  2001        PMID: 11516049     DOI: 10.1177/000992280104000801

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  4 in total

1.  Achieving control of asthma in preschoolers.

Authors:  Thomas Kovesi; Suzanne Schuh; Sheldon Spier; Denis Bérubé; Stuart Carr; Wade Watson; R Andrew McIvor
Journal:  CMAJ       Date:  2009-11-23       Impact factor: 8.262

2.  Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.

Authors:  Alexandra Ahmet; Harold Kim; Sheldon Spier
Journal:  Allergy Asthma Clin Immunol       Date:  2011-08-25       Impact factor: 3.406

3.  Inhaled corticosteroids and secondary adrenal insufficiency.

Authors:  Vishnu Sannarangappa; Ryan Jalleh
Journal:  Open Respir Med J       Date:  2014-01-31

4.  A systematic review of the implementation and impact of asthma protocols.

Authors:  Judith W Dexheimer; Elizabeth M Borycki; Kou-Wei Chiu; Kevin B Johnson; Dominik Aronsky
Journal:  BMC Med Inform Decis Mak       Date:  2014-09-09       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.